[{"Assets_0_Q3_USD":917392000.0,"CommonStockSharesConverted_0_Q3_shares":124316080.0,"CommonStockSharesOutstanding_0_Q3_shares":124316080.0,"EarningsPerShareBasic_1_Q3_USD":-0.11,"EarningsPerShareBasic_3_Q3_USD":-0.97,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":232195000.0,"NetIncomeLossConverted_1_Q3_USD":-13950000.0,"StockholdersEquity_0_Q3_USD":585925000.0,"NetIncomeLossConverted_3_Q3_USD":-48959000.0,"RevenuesConverted_1_Q3_USD":26058000.0,"RevenuesConverted_3_Q3_USD":60862000.0,"Ticker":"ADPT","CIK":"1478320","name":"ADAPTIVE BIOTECHNOLOGIES CORP","OfficialName":"Adaptive Biotechnologies Corporation Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1463975665.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20191112"}]